Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes
Status:
Not yet recruiting
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
The primary objective of this pilot study is to assess the feasibility and acceptability of
an intervention for improved detection and evidence-based care of NAFLD in Latinx and Black
patients with type 2 diabetes (T2D) in Duke University Healthcare system (DUHS). We will
enroll 10-15 Latinx and 10-15 Black patients with T2D and NAFLD, based on having mildly
elevated liver enzymes (ALT >/= 40 IU/mL in males, ALT >/= 31 IU/mL in females) and exclusion
of other liver diseases (e.g., viral hepatitis, alcohol abuse).
Intervention content will include: 1) NAFLD education; 2)diet/lifestyle support; 3) T2D
medication management; and 4) clinically-indicated liver testing and care.
Intervention feasibility will be evaluated by examining recruitment rates, retention rates,
and study visit completion rates. Acceptability will be assessed by survey and through
qualitative interviews. The project objectives and intervention are minimal risk. The
expected risks will not exceed those of usual care.